vania-janet/multiturn-rag-retrieval-data huggingface dataset:
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
Persons reporting symptoms other than hives after exposure to egg (such as angioedema, respiratory distress, lightheadedness, or recurrent emesis; or who required epinephrine or another emergency medical intervention) may also receive any licensed and recommended flu vaccine that is otherwise appropriate.

Additionally, for these persons, vaccine should be administered in an inpatient or outpatient medical setting and supervised by a health care provider who is able to recognize and manage severe allergic reactions.

A previous severe allergic reaction to flu vaccine, regardless of the component suspected of causing the reaction, is a contraindication to future receipt of the vaccine.

Implications of Cell-Based Vaccines
Why is it significant that cell-grown vaccine viruses are used to produce one flu vaccine?
Cell-grown vaccine viruses do not have changes that may be present in egg-grown reference viruses, so they should be more similar to circulating “wild-type” viruses. Vaccine effectiveness depends in part on the match between the vaccine virus and circulating flu viruses.
Is flu vaccine made using a cell-grown vaccine virus and cell-based technology more effective than vaccine made using an egg-grown vaccine virus and egg-based technology?
While the use of cell-grown vaccine viruses and cell-based technology may offer the potential for better protection over traditional, egg-based flu vaccines because they result in vaccine viruses that are more similar to flu viruses in circulation, there are no vaccine effectiveness data to support this. There is no preferential recommendation for one flu vaccine over another.
Top of PageFlu Activity
What sort of flu season is expected this year?
Influenza is unpredictable. While flu spreads every year, the timing, severity, and length of the season varies from one season to another.
Will new flu viruses circulate this season?
Flu viruses are constantly changing so it’s not unusual for new flu viruses to appear each year. More information about how flu viruses change is available.
Will the United States have a flu epidemic?
The United States experiences annual epidemics of seasonal flu. This time of year is called “flu season.” In the United States, flu viruses are most common during the fall and winter months. Flu activity often begins to increase in October and November.
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
For the 2019-2020 flu season, providers may choose to administer any licensed, age-appropriate flu vaccine (IIV, RIV4, or LAIV4).
Options this season include:

Standard dose flu shots. Like all inactivated influenza vaccines, these are given into the muscle. They are usually given with a needle, but one (Afluria Quadrivalent) can be given to some people (those 18 to 64 years old) with a jet injector.
High-dose shots for people 65 years and older.
Shots made with adjuvant for people 65 years and older.
Shots made with virus grown in cell culture. No eggs are involved in the production of this vaccine.
Shots made using a vaccine production technology (recombinant vaccine) that does not require the use of flu virus.
Live attenuated influenza vaccine (LAIV). – A vaccine made with attenuated live virus that is given by nasal spray vaccine.

There is a table showing all flu vaccines that are FDA-approved for use in the United States during the 2019-2020 season.
What viruses will the 2019-2020 flu vaccines protect against?
There are many different flu viruses and they are constantly changing. The composition of U.S. flu vaccines is reviewed annually and updated as needed to match circulating flu viruses. Flu vaccines protect against the three or four viruses (depending on the vaccine) that research suggests will be most common. For 2019-2020, trivalent (three-component) vaccines are recommended to contain:

A/Brisbane/02/2018 (H1N1)pdm09-like virus (updated)
A/Kansas/14/2017 (H3N2)-like virus (updated)
B/Colorado/06/2017-like (Victoria lineage) virus

Quadrivalent (four-component) vaccines, which protect against a second lineage of B viruses, are recommended to contain:

the three recommended viruses above, plus B/Phuket/3073/2013-like (Yamagata lineage) virus.

FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) chooses the flu vaccine viruses for the United States.
FAQs • Assessor


FAQs • Assessor

 

Skip to Main Content

 

Search

 
 
 

Your GovernmentCommunityCounty DepartmentsHow Do I

 

 

 

 

 
HomeFAQs

Search

All categories
Assessor
Behavioral Health
Child Health and Disability Prevention (CHDP)
COVID Vaccine Myths
Emergency Preparedness
Grand Jury
Main
Public Health - Opioid Safety
Public Health Immunizations
Solid Waste
Tobacco Use Reduction Program (TURP)
Woman Infants and Children (WIC)

Categories

All Categories

Assessor

Behavioral Health

Child Health and Disability Prevention (CHDP)

COVID Vaccine Myths

Emergency Preparedness

Grand Jury

Main

Public Health - Opioid Safety

Public Health Immunizations

Solid Waste

Tobacco Use Reduction Program (TURP)

Woman Infants and Children (WIC)

▼
Assessor	

Show All Answers

1.
How do I pay my taxes?

Tax payments are made to the Tax Collector. Find more Information here:  	Online payments

2.
What is a lien date?

The lien date is the date of valuation of property on the local assessment roll. It is the date when property taxes become a lien on property preceding the fiscal year (July 1 through June 30) for which those taxes are levied. Since 1997, the lien date has been January 1. This means property is valued and property taxes become a lien on January 1 each year. (Revenue and Taxation Codes 117 and 405)	

3.
What is a supplemental assessment?

Supplemental assessments are one-time assessments, which are distinct from regular annual assessments. A supplemental assessment is created each time property is revalued due to a change in ownership or new construction. It is the difference between the prior and the new assessed values. (Revenue and Taxation Code 75-75.72)	

Live Edit

 

 

Agendas & Minutes

Bids and RFP's

Job Opportunities

Make a Payment

Ordinance Code

Public Notices

Resource Guide

 

 

EmergencyInformation

OnlinePayments

 
 

Agendas& Minutes

CountyOrdinance Code

 
 

Jobs

View PropertyTax bills

 
 
 

 

 

  
 

  
 

Contact Us

Sierra County Courthouse100 Courthouse Square #200Downieville, CA 95936Phone: 530-289-3698
 

  
 

  
 

Quick Links

Current Projects

Projects & Public Hearings

CA Chief Probation Officers

Proposition 13 FAQ

/QuickLinks.aspx

 
 

  
 

Site Links

Bids & RFP's

Site Map

Contact Us

Accessibility

/QuickLinks.aspx

 
 
 

 

    

 
 

Government Websites by CivicPlus®

 
 

  
 
 

Loading


	Loading
	

Do Not Show Again
Close

Arrow Left

Arrow Right

[]

Slideshow Left Arrow

Slideshow Right Arrow
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
Are any of the available flu vaccines recommended over the others?
For the 2019-2020 flu season, ACIP recommends annual flu vaccination for everyone 6 months and older with any licensed, age-appropriate flu vaccine (IIV, RIV4, or LAIV4) with no preference expressed for any one vaccine over another.
There are many vaccine options to choose from; the most important thing is for all people 6 months and older to get a flu vaccine every year. If you have questions about which vaccine is best for you, talk to your doctor or other health care professional.
Why is the nasal spray being recommended as an option this year when it has been shown to not be effective in past flu seasons?
Flu vaccine effectiveness (VE) can vary from year to year, among different age and risk groups, by vaccine type, and even by virus type and subtype. While data from 2010-2011 through 2016-2017 indicated that nasal spray vaccine lacked effectiveness among 2 through 17-year-olds against H1N1 viruses in the U.S., nasal spray vaccine was effective against influenza B viruses, and was similarly effective against H3N2 viruses as inactivated influenza vaccines. Since the 2018-2019 season, the manufacturer of nasal spray vaccine has used a new H1N1 vaccine virus in production. Some data suggest this will result in improved effectiveness of against H1N1. However, no published effectiveness estimates for this vaccine component against H1N1 viruses are available. ACIP and CDC voted to resume the recommendation for the use of nasal spray vaccines based on evidence suggesting that the new H1N1 component will result in improved effectiveness of the vaccine against these viruses. There is no expressed preference for any flu shot or the nasal spray vaccine.
Where can I get a flu vaccine?
Flu vaccines are offered by many doctor’s offices, clinics, health departments, pharmacies and college health centers, as well as by many employers, and even by some schools.
Even if you don’t have a regular doctor or nurse, you can get a flu vaccine somewhere else, like a health department, pharmacy, urgent care clinic, and often your school, college health center, or work.
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
However, even during years when the vaccine match is good, the benefits of flu vaccination will vary across the population, depending on host factors like the health and age of the person being vaccinated and even potentially which flu vaccine was used.
Recent studies by CDC researchers and other researchers suggest that flu vaccination usually reduces the risk of influenza illness by 40% to 60% among the overall population when the vaccine viruses are like the ones spreading in the community.
For more information about vaccine effectiveness, click here. 
Will this season’s flu vaccine be a good match for circulating viruses?
It’s not possible to predict with certainty if a flu vaccine will be a good match for circulating flu viruses. A flu vaccine is made to protect against the flu viruses that research and surveillance indicate will likely be most common during the season. However, scientists must pick which flu viruses to include in a flu vaccine many months in advance in order for flu vaccines to be produced and delivered on time. Also flu viruses change constantly (called “drift”). They can change from one season to the next or they can even change within the course of one flu season. Another factor that can impact vaccine effectiveness, especially against influenza A(H3N2) viruses, are changes that can occur in vaccine viruses as they are grown in eggs, which is the production method for most current flu vaccines. Because of these factors, there is always the possibility of a less than optimal match between circulating flu viruses and the viruses in a flu vaccine.
Over the course of flu season, CDC studies samples of circulating flu viruses to evaluate how close a match there is between viruses used to make the flu vaccine and circulating flu viruses.
One of the ways that helps CDC evaluate the match between flu vaccine viruses and circulating flu viruses is with a lab process called ‘genetic and antigenic characterization’. Results of genetic and antigenic characterization testing are published weekly in CDC’s FluView.
Can a flu vaccine provide protection even if the flu vaccine is not a “good” match?
Yes, antibodies made in response to vaccination with one flu virus sometimes can provide protection against different but related flu viruses.
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
Detect changes in flu viruses
Measure the impact flu is having on hospitalizations and deaths in the United States

For more information, visit “Overview of Influenza Surveillance in the United States”.
What will CDC do to monitor flu vaccine effectiveness for the 2019-2020 season?
CDC collaborates with partners each season to assess how well the seasonal flu vaccines are working. During the 2019-2020 season, CDC is planning multiple studies on the effectiveness of flu vaccines. Researchers conduct these studies each year to measure how well flu vaccines work in order to continually assess and confirm their value as a public health measure.
Part of the need for this continued assessment is that flu viruses that circulate each year tend to change and evolve, and so the components of the flu vaccine are changed relatively frequently to protect against these new circulating viruses. A summary of CDC’s latest vaccine effectiveness estimates is available at Seasonal Influenza Vaccine Effectiveness, 2005-2018.
What is CDC doing to monitor antiviral resistance in the United States during the 2019-2020 season?
Antiviral resistance means that a virus has changed in such a way that antiviral drugs are less effective or not effective at all in treating or preventing illnesses with that virus. CDC will continue to collect and monitor flu viruses for changes through an established network of domestic and global surveillance systems. CDC also is working with the state public health departments and the World Health Organization to collect additional information on antiviral resistance in the United States and worldwide. The information collected will assist in making informed recommendations regarding use of antiviral drugs to treat flu.
Top of PageHow does CDC estimate the burden of seasonal flu on the United States?
The burden of flu on the United States can vary widely from season to season and is determined by a number of factors including the characteristics of circulating viruses, the timing of the season, population immunity to circulating viruses, how well flu vaccines are working, and how many people have gotten vaccinated. While the impact of flu varies, it places a substantial burden on the health of people in the United States each year.
CDC uses a model to estimate the numbers of flu illnesses, medical visits, and hospitalizations in the United States (as well as the impact of flu vaccination on these numbers).
Search & Browse | Page 1 of 25 | State of New York
novel coronavirus
sars-cov2

 API Docs
 

 Updated
 

September 1 2023

 Views
 

 703,001
 

Medicaid Enrolled Provider Lookup

Story

Search Medicaid Enrolled Provider data with these interactive graphs and search cards.

 Tags
 

 No tags assigned
 

 Updated
 

May 1 2024

 Views
 

 647,571
 

Interactive Ancestry/Genealogical Research Death Index

Story

You can quickly research and filter the Genealogical Research Death Index data starting in 1957 with these easy to use, interactive search and visualization cards. Just follow the tips by clicking on the below "Show More" arrow. The data is refreshed on a quarterly basis.

Quick tips: First, use the search cards to explore the data. As you enter your requested information, a sample of available data is displayed to help your search. 
Next, you can hover over the graphs, to further filter the data. For example, on the "Date of Death" timeline or the "Decedent Age" graphs you are able to select a time frame and/or age range by hovering over the desired dates/ages. If you just want to search a particular year, click on the year in the "Year of Death" card. The table will change with each search and filter that you apply. There is also a description of what you are filtering above the cards.
Click the "Clear All" button above the cards on the left hand side to remove all filter(s). 

Important reminders:  The Genealogical Research Death Index contains a variety of genealogy
criteria on decedents, date of death, gender, age at death and NYS file number
that will allow the public to search for individuals who
died at least 50 years ago  in New York State, outside of New York City.  For more information, check out http://www.health.ny.gov/vital_records/genealogy.

 Tags
 

 No tags assigned
 

 Updated
 

July 20 2023

 Views
 

 557,750
 

Food Service Establishment: Last Inspection

Health

Dataset
Frequently Asked Influenza (Flu) Questions: 2019-2020 Season | CDC
The A(H3N2) vaccine component was updated from an A/Singapore/INFIMH-16-0019/2016 A(H3N2)-like virus to an A/Kansas/14/2017 (H3N2)-like virus.
Both B/Victoria and B/Yamagata virus components from the 2018-2019 flu vaccine remain the same for the 2019-2020 flu vaccine.

All regular-dose flu shots will be quadrivalent. (No trivalent regular-dose flu shots will be available this season.)
All recombinant vaccine will be quadrivalent. (No trivalent recombinant vaccine will be available this season.)
All four of the vaccine viruses used to produce cell-grown flu vaccine will have been grown in cells, not eggs.
In January 2019, the U.S. Food and Drug Administration (FDA) approved a change in dose volume for Fluzone Quadrivalent, a quadrivalent inactivated influenza vaccine.

The change in dose volume affects children 6 through 35 months of age.
Previously, children in this age group were recommended to receive 0.25 milliliters of this vaccine per dose.
Children 6 through 35 months of age may now receive either 0.25 milliliters or 0.5 milliliters per dose.
There is no preference for one or the other dose volume for this age group. All persons 36 months (or 3 years) of age and older should receive 0.5 milliliters per dose.

In October 2018, FDA approved an expanded age indication for Afluria Quadrivalent, a quadrivalent inactivated influenza vaccine. Afluria Quadrivalent is now licensed for children 6 months of age and older. Children 6 months through 35 months of age should receive 0.25 milliliters for each dose. All persons 36 months (or 3 years) of age and older should receive 0.5 milliliters for each dose.
Baloxavir marboxil (trade name Xofluza®) is a new flu single-dose antiviral drug approved October 24, 2018 by FDA.
Contact the National Archives | National Archives
Select one...General QuestionCensus RecordsCourt RecordsFederal Civilian Agency Records (no personnel records after 1900)Federal Civilian Personnel Records (from 1900-1952)*Federal Civilian Personnel Records (from 1952 to Present)*Genealogy - Related Records (immigration, naturalization, passports, visas, etc.)John F. Kennedy assassination records collectionDigitized Records (documents,photos) in the National Archives CatalogNative American RecordsOSS Records (including personnel records)Presidential MaterialsRecords of CongressSpecial media (audio, video, film, photos, aerial photos, maps, plans)State Department RecordsUnited States Military Personnel Records (from 1905-1954)*United States Military Personnel Records (from 1954 to present)* Which online system did you use to order records? *
-Select-Digital Delivery Portal (edelivery.archives.gov) downloading response documentseVetRecs (vetrecs.archives.gov) requesting veteran's recordsOrderOnline (eservices.archives.gov) ordering reproductions of original records Which user account are you having an issue with? *
-Select-OrderOnline (eservices.archives.gov)National Archives Catalog (catalog.archives.gov)Citizen Archivist - transcribing or tagging recordsHistory Hub (historyhub.history.gov) Which website are you having an issue with? *
-Select-Digital Delivery Portal (edelivery.archives.gov)eVetRecs (vetrecs.archives.gov)OrderOnline (eservices.archives.gov)National Archives Catalog (catalog.archives.gov)National Archives Website (archives.gov)Other Request Number
 Request Number
What is your question?

Don't see your question?
History Hub is a crowdsourcing platform sponsored by the National Archives. It is a place to ask questions, share information, work together, and find people based on their experience and interests.
Ask History Hub Ask NARA Directly

 Please tell us more. *
 Would you like us to send you a response? *
Please select Yes or NoYesNo

 First Name *
 Last Name *
 Email Address *
 Country *
Respiratory Syncytial Virus (RSV) Infection
Respiratory syncytial virus (RSV) infection is a common respiratory illness caused by a virus. Anyone can be infected, but RSV most often causes serious illness in infants and very young children, older adults, or those with a weakened immune system or illnesses like heart disease, chronic lung disease, and diabetes. Much like other respiratory viruses, RSV infections typically occur during the fall and winter.
How does RSV spread?
RSV is spread through contact with droplets from the nose and throat of infected people when they cough and sneeze. RSV can also spread through dried respiratory secretions on bedclothes and similar items. Direct contact with the virus, such as kissing, can also spread the virus. RSV can remain infectious on hard surfaces for several hours and on skin for shorter amounts of time.
What are RSV symptoms?
Typical symptoms resemble the common cold: runny nose, coughing, sneezing, fever, wheezing, and decreased appetite. Mild or unnoticeable illness may occur. However, RSV infection can also result in pneumonia, especially in the very young, the very old, or those with weakened immune systems. Individuals can also be infected with multiple respiratory viruses at the same time, which can cause more serious complications.
Symptoms generally begin four to six days after exposure. Symptoms generally develop slowly over a period of several days. The contagious period is usually less than 10 days after symptoms begin, but occasionally is longer. Symptoms, particularly a cough, may persist for a few days to several weeks.
How is RSV diagnosed?
RSV is diagnosed by a pediatrician/health care provider. It is usually identified from the appearance of typical symptoms. The use of specific laboratory tests is often limited to cases of severe illness and to special outbreak investigations. The most common laboratory tests use a swab or respiratory fluid to look for the virus.
If my child or I have symptoms consistent with RSV, what should I do?
If you or your child have symptoms consistent with RSV, or any respiratory illness, and you are concerned about severe illness, contact a health care provider right away who can help you with diagnosis, treatment, and care.
LGBTQIA+ History - NYS Parks, Recreation & Historic Preservation

LGBTQIA+ History - NYS Parks, Recreation & Historic Preservation


 Your browser does not support iFrames
 

Navigation menu

Parks, Recreation and Historic Preservation

Visit

State Parks
Historic Sites
Nature Centers
Events
Golf Courses
Trails
Admission
Accessibility
Love Our New York Lands

Get Active

Hiking
Boating
Swimming
Golf
Pavilions
Hunting
Snowmobiling

Camp

Overview
Campsites
Cottages
Cabins
Group Camping
Fees & Rates
Camper Assistance Program
Know before you go

Connect to Nature

The Environment
Nature Centers
Nature Nearby
Connect Kids
FORCES
Ladders to the Outdoors

Discover History

Historic Business Preservation Registry
Historic Sites
Historic Preservation Office
Bureau of Historic Sites
Heritage Trail
Heritage Areas
We Are NY
Black History
Women's History
LGBTQIA+ History
Dutch Heritage

 

LGBTQIA+ History

Home / History / LGBTQIA+ History

LGBTQIA+ is an acronym used to represent the lesbian, gay, bisexual, transgender, queer or questioning, intersex, asexual, plus community. This umbrella term includes people
	 with various sexual orientations, gender identities, and sexes. The LGBTQIA+ community has been excluded from traditional historical narratives, and this page is meant to
	 begin to share their stories and rich history within New York State. It is important to note that the LGBTQIA+ movement has not always supported the intersectional experiences
	 of individuals who are part of it, including transgender and gender non-conforming people and people of color. Additionally, you will notice that this page disproportionately
	 represents the New York City region. This is because NYC has the largest LGBTQIA+ identifying population in the state. LGBTQIA+ folks have built communities in many
	 non-NYC areas, many just to survive, and it is a continued effort to uncover this history in other regions. On this page, you will find a non-extensive list of notable sites and